albendazole + dexamethasone

Albendazole + dexamethasone is a combination therapy consisting of albendazole, a benzimidazole anthelmintic, and dexamethasone, a synthetic glucocorticoid corticosteroid. This combination is primarily used in the treatment of neurocysticercosis and other helminth infections where inflammation due to parasite death can exacerbate symptoms. Albendazole acts by inhibiting microtubule polymerization in susceptible parasites, leading to impaired glucose uptake and energy depletion in the worm. Dexamethasone reduces inflammation by suppressing immune responses and cytokine production. The co-administration of dexamethasone with albendazole helps prevent or reduce acute inflammatory reactions triggered by cysticidal therapy and has been shown to increase plasma levels of albendazole's active metabolite (albendazole sulfoxide), potentially enhancing its efficacy[1][2][8]. Clinical studies indicate that this combination improves lesion resolution rates and reduces seizure recurrence in neurocysticercosis patients[8].